Yagami (NGO:7488) ROCE %: 15.65% (As of Apr. 2026)

What is Yagami ROCE %?

Yagami NGO:7488 -2.45% 67 ROCE % is 15.65% as of Apr. 2026. GuruFocus rates NGO:7488 with a GF Score™ of 67/100 and a GF Value™ of 円3,129.79 (Significantly Overvalued). The stock has 1 warning sign investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Yagami's annualized ROCE % for the quarter that ended in Apr. 2026 was 15.65%.

Yagami (NGO:7488) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Yagami ROCE % Related Terms

Yagami ROCE % Historical Data

* Premium members only.

The historical data trend for Yagami's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yagami ROCE % Chart

Yagami Annual Data

Trend

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Apr24

Apr25

Apr26

ROCE %

Get a 7-Day Free Trial

14.50

12.82

12.54

13.30

15.46

Yagami Semi-Annual Data
	Oct16	Apr17	Oct17	Apr18	Oct18	Apr19	Oct19	Apr20	Oct20	Apr21	Oct21	Apr22	Oct22	Apr23	Oct23	Apr24	Oct24	Apr25	Oct25	Apr26
ROCE %	Get a 7-Day Free Trial															14.41	12.84	13.69	15.16	15.65

67GF Score

Yagami Inc NGO:7488

ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Yagami ROCE % Calculation

Yagami's annualized ROCE % for the fiscal year that ended in Apr. 2026 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Apr. 2026 )		(A: Apr. 2025 )		(A: Apr. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Apr. 2026 )		(A: Apr. 2025 )		(A: Apr. 2026 )
	=	2296.095	/	( ( (18546.948 - 3885.475)	+	(18076.693 - 3038.403) )	/ 2 )
	=	2296.095	/	( (14661.473	+	15038.29)	/ 2 )
	=	2296.095	/	14849.8815
	=	15.46 %

Yagami's ROCE % of for the quarter that ended in Apr. 2026 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Apr. 2026 )		(Q: Oct. 2025 )		(Q: Apr. 2026 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Apr. 2026 )		(Q: Oct. 2025 )		(Q: Apr. 2026 )
	=	2347.106	/	( ( (18113.912 - 3159.028)	+	(18076.693 - 3038.403) )	/ 2 )
	=	2347.106	/	( ( 14954.884	+	15038.29 )	/ 2 )
	=	2347.106	/	14996.587
	=	15.65 %

(1) Note: The EBIT data used here is two times the semi-annual (Apr. 2026) EBIT data.

Frequently Asked Questions Learn more about ROCE % →

What does a ROCE % of 15.65% mean?

Yagami (NGO:7488) has a ROCE % of 15.65% as of Apr. 2026.

Is Yagami's ROCE % too high?

Yagami's current ROCE % is 15.65%. The Medical Distribution industry median ROCE % is 8.92. Yagami's value of 15.65% is 75.4% above this industry median. Overall, Yagami has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Yagami's ROCE % compare to MCK and CAH?

Yagami's ROCE % of 15.65% can be compared against companies in the Medical Distribution industry. The industry median ROCE % is 8.92. Yagami's value of 15.65% is 75.4% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good ROCE % for a Medical Distribution company?

The median ROCE % among Medical Distribution companies is 8.92, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Yagami's current ROCE % of 15.65% is 75.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high ROCE % mean?

A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Distribution industry, the median ROCE % is 8.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Yagami's current ROCE % is 15.65%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Yagami stock overvalued right now?

Based on GuruFocus' analysis, Yagami (NGO:7488) is currently considered Significantly Overvalued. The stock's GF Value™ is 円3,129.79, compared to a current price of 円4,780.00 — trading 52.7% above its estimated fair value. The current ROCE % is 15.65% and 75.4% above the Medical Distribution industry median of 8.92. Yagami's overall GF Score™ is 67/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is ROCE % calculated?

ROCE % is calculated from a company's financial statements. For Yagami (NGO:7488), the current ROCE % is 15.65% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Yagami (NGO:7488) Overvalued in 2026?

Based on GuruFocus' analysis, Yagami stock appears to be overvalued. The current stock price of 円4,780.00 is trading 52.7% above its estimated GF Value™ of 円3,129.79. GuruFocus considers Yagami to be Significantly Overvalued.

Key valuation signals for NGO:7488:

ROCE %: 15.65%
GF Value™: 円3,129.79 vs. price of 円4,780.00 (52.7% above fair value)
GF Score™: 67/100 with 1 warning sign
Industry Position: 75.4% above the Medical Distribution median

No single metric tells the full story. See the NGO:7488 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Yagami Business Description

Industry Healthcare Medical Distribution

Comparable Companies TSE:3183 SSE:3055 TSE:7634 TSE:2689 TSE:9265 TSE:7681 TSE:3151 MCK CAH COR ASX:SIG HSIC SHSE:601607 HKSE:01099 XSWX:GALE SHSE:600332 SHSE:600998 TSE:7459 OSTO:ASKER MIL:AMP

Address No. 29, No. 3, Marunouchi, Naka-ku, Nagoya, JPN, 460 0002

Website https://www.yagami-inc.co.jp

Yagami Inc is a Japan based company engaged in providing science education equipment, laboratory tables, kitchen tables, sterilizers, nurse's office equipment, AEDs (automated external defibrillators), human body models for resuscitation education, electric heaters for keeping warm and heating, and environmental testing equipment.

67GF Score

Get the complete analysis for NGO:7488

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円4,780.00

Price

円3,129.79

GF Value

View NGO:7488 Analysis

See ROCE % data for all stocks →